Concepedia

Publication | Open Access

Sotorasib in <i>KRAS</i> p.G12C–Mutated Advanced Pancreatic Cancer

DOIFull Paper Access

425

Citations

28

References

2022

Year

John H. Strickler, Hironaga Satake, Thomas J. George, Rona Yaeger, Antoine Hollebecque, Ignacio Garrido‐Laguna, Martin Schüler, Timothy F. Burns, Andrew L. Coveler, Gerald S. Falchook,
New England Journal of Medicine

Abstract

Sotorasib showed anticancer activity and had an acceptable safety profile in patients with <i>KRAS</i> p.G12C-mutated advanced pancreatic cancer who had received previous treatment. (Funded by Amgen and others; CodeBreaK 100 ClinicalTrials.gov number, NCT03600883.).

References

YearCitations

Page 1